Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
March-2017 Volume 13 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
March-2017 Volume 13 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

PUMA decreases the growth of prostate cancer PC-3 cells independent of p53

  • Authors:
    • Zhengfei Shan
    • Qingzuo Liu
    • Yuling Li
    • Jitao Wu
    • Dekang Sun
    • Zhenli Gao
  • View Affiliations / Copyright

    Affiliations: Department of Urology, Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University, Yantai, Shandong 264000, P.R. China, Department of Pathophysiology, Binzhou Medical University, Yantai, Shandong 264000, P.R. China
  • Pages: 1885-1890
    |
    Published online on: January 27, 2017
       https://doi.org/10.3892/ol.2017.5657
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

PUMA (p53 upregulated modulator of apoptosis), a member of the B‑cell lymphoma 2 (Bcl-2) protein family, is a pro‑apoptotic protein. PUMA expression is modulated by the tumor suppressor p53. PUMA has a role in rapid cell death via p53‑dependent and ‑independent mechanisms. To evaluate whether p53 is required for PUMA‑mediated apoptosis in prostate cancer cells, p53 protein was silenced in human prostate cancer PC‑3 cells by using p53 small interfering RNA (siRNA). The interference efficiency of p53 on RNA and protein levels was detected by reverse transcription-quantitative polymerase chain reaction and western blotting. Cell proliferation and p21 expression were subsequently examined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and western blot analysis, respectively. p53‑silenced or control PC‑3 cells were transfected with pCEP4‑(hemagglutinin)‑PUMA plasmid, or non‑carrier plasmid. Enzyme‑linked immunosorbent assay was used to determine cell apoptosis by measuring histone release and caspase‑3 activation, and MTT assay was used to measure cell viability. In addition, the expression of pro‑apoptosis protein Bax and anti‑apoptosis protein Bcl‑2 were evaluated. The results of the present study revealed that p53 siRNA significantly suppressed p53 RNA and protein expression in PC‑3 cells. Deficiency of p53 increased the cell growth rate and decreased p21 expression. However, PUMA overexpression remained able to induce apoptosis in p53‑silenced and control cells by increasing Bax expression and decreasing Bcl‑2 expression, leading to the activation of caspase‑3. These results suggest that PUMA may mediate apoptosis of prostate cancer PC‑3 cells, potentially independently of p53. Furthermore, PUMA gene treatment to induce cancer cell apoptosis may be more efficient compared with p53‑dependent apoptosis, where loss of p53 expression or function may lead to limited efficacy of PUMA expression. Therefore, the present study proposes the significant hypothesis that increasing PUMA expression may be an effective approach for the treatment of prostate cancer, regardless of p53 status.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Mandal A: Prostate Cancer, . NEWS MEDICAL. The Latest Developments in Life Sciences & Medicine. http://www.news-medical.net/health/Prostate-Cancer.aspxAccessed. February 27–2015.

2 

Tsai SC, Lu CC, Lee CY, Lin YC, Chung JG, Kuo SC, Amagaya S, Chen FN, Chen MY, Chan SF and Yang JS: AKT serine/threonine protein kinase modulates bufalin-triggered intrinsic pathway of apoptosis in CAL 27 human oral cancer cells. Int J Oncol. 41:1683–1692. 2012.PubMed/NCBI

3 

Umit UM, Berna T, Handan K, Ipek E, Berrak Y, Can E and Bahadir GM: Role of melatonin and luzindole in rat mammary cancer. J Invest Surg. 25:345–353. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Nakano K and Vousden KH: PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 7:683–694. 2001. View Article : Google Scholar : PubMed/NCBI

5 

Han J, Flemington C, Houghton AB, Gu Z, Zambetti GP, Lutz RJ, Zhu L and Chittenden T: Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci USA. 98:11318–11323. 2001. View Article : Google Scholar : PubMed/NCBI

6 

Liu H, Li W, Yu X, Gao F, Duan Z, Ma X, Tan S, Yuan Y, Liu L, Wang J, et al: EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis. Oncotarget. Jul 26–2016.(Epub ahead of print).

7 

Jang Y, Kim J, Ko JW and Kwon YH: Homocysteine induces PUMA-mediated mitochondrial apoptosis in SH-SY5Y cells. Amino Acids. 48:2559–2569. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Ma J, Feng Y, Liu Y and Li X: PUMA and survivin are involved in the apoptosis of HepG2 cells induced by microcystin-LR via mitochondria-mediated pathway. Chemosphere. 157:241–249. 2016. View Article : Google Scholar : PubMed/NCBI

9 

Sun Y, Xia P, Zhang H, Liu B and Shi Y: P53 is required for Doxorubicin-induced apoptosis via the TGF-beta signaling pathway in osteosarcoma-derived cells. Am J Cancer Res. 6:114–125. 2015.PubMed/NCBI

10 

Wang P, Yu J and Zhang L: The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc Natl Acad Sci USA. 104:4054–4059. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J, MacLean KH, Han J, Chittenden T, Ihle JN, et al: Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell. 4:321–328. 2003. View Article : Google Scholar : PubMed/NCBI

12 

Avila JL, Grundmann O, Burd R and Limesand KH: Radiation-induced salivary gland dysfunction results from p53-dependent apoptosis. Int J Radiat Oncol Biol Phys. 73:523–529. 2009. View Article : Google Scholar : PubMed/NCBI

13 

Niizuma K, Endo H, Nito C, Myer DJ and Chan PH: Potential role of PUMA in delayed death of hippocampal CA1 neurons after transient global cerebral ischemia. Stroke. 40:618–625. 2009. View Article : Google Scholar : PubMed/NCBI

14 

Zhao Y, Coloff JL, Ferguson EC, Jacobs SR, Cui K and Rathmell JC: Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation. J Biol Che. 283:36344–36353. 2008. View Article : Google Scholar

15 

Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD and Green DR: PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science. 309:1732–1735. 2005. View Article : Google Scholar : PubMed/NCBI

16 

Gomez-Lazaro M, Galindo MF, Fernandez-Gomez FJ, Prehn JH and Jordán J: Activation of p53 and the pro-apoptotic p53 target gene PUMA during depolarization-induced apoptosis of chromaffin cells. Exp. Neurol. 196:96–103. 2005.

17 

Wong HK, Fricker M, Wyttenbach A, Villunger A, Michalak EM, Strasser A and Tolkovsky AM: Mutually exclusive subsets of BH3-only proteins are activated by the p53 and c-Jun N-terminal kinase/c-Jun signaling pathways during cortical neuron apoptosis induced by arsenite. Mol Cell Biol. 25:8732–8747. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Yu J, Wang P, Ming L, Wood MA and Zhang L: SMAC/Diablo mediates the proapoptotic function of PUMA by regulating PUMA-induced mitochondrial events. Oncogene. 26:4189–4198. 2007. View Article : Google Scholar : PubMed/NCBI

19 

Giannakakou P, Nakano M, Nicolaou KC, O'Brate A, Yu J, Blagosklonny MV, Greber UF and Fojo T: Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics. Proc Natl Acad Sci USA. 99:10855–10860. 2002. View Article : Google Scholar : PubMed/NCBI

20 

Kalousek I, Brodska B, Otevrelova P and Röselova P: Actinomycin D upregulates proapoptotic protein Puma and downregulates Bcl-2 mRNA in normal peripheral blood lymphocytes. Anticancer Drugs. 18:763–772. 2007. View Article : Google Scholar : PubMed/NCBI

21 

Fernandez PC, Frank SR, Wang L, Schroeder M, Liu S, Greene J, Cocito A and Amati B: Genomic targets of the human c-Myc protein. Genes Dev. 17:1115–1129. 2003. View Article : Google Scholar : PubMed/NCBI

22 

Maclean KH, Keller UB, Rodriguez-Galindo C, Nilsson JA and Cleveland JL: c-Myc augments gamma irradiation-induced apoptosis by suppressing Bcl-XL. Mol Cell Biol. 23:7256–7270. 2003. View Article : Google Scholar : PubMed/NCBI

23 

Yu J and Zhang L: PUMA, a potent killer with or without p53. Oncogene. 27:(Suppl 1). S71–S83. 2008. View Article : Google Scholar : PubMed/NCBI

24 

Castedo M, Perfettini JL, Piacentini M and Kroemer G: p53 - A pro-apoptotic signal transducer involved in AIDS. Biochem Biophys Res Commun. 331:701–706. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Yee KS and Vousden KH: Contribution of membrane localization to the apoptotic activity of PUMA. Apoptosis. 13:87–95. 2008. View Article : Google Scholar : PubMed/NCBI

26 

Vogelstein B and Kinzler KW: Cancer genes and the pathways they control. Nat Med. 10:789–799. 2004. View Article : Google Scholar : PubMed/NCBI

27 

Yu J and Zhang L: The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun. 331:851–858. 2005. View Article : Google Scholar : PubMed/NCBI

28 

Hao and Cho WC: Battle against cancer: An everlasting saga of p53. Int J Mol Sci. 15:22109–22127. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Livak and Schmittgen, . Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

30 

Pap T, Aupperle KR, Gay S, Firestein GS and Gay RE: Invasiveness of synovial fibroblasts is regulated by p53 in the SCID mouse in vivo model of cartilage invasion. Arthritis Rheum. 44:676–681. 2001. View Article : Google Scholar : PubMed/NCBI

31 

Pommier Y, Sordet O, Antony S, Hayward RL and Kohn KW: Apoptosis defects and chemotherapy resistance: Molecular interaction maps and networks. Oncogene. 23:2934–2949. 2004. View Article : Google Scholar : PubMed/NCBI

32 

Hirscheler B: Europe gives green light to first gene therapy for children. http://www.arabtimesonline.com/wp-content/uploads/pdf/2016/apr/03/29.pdfAccessed. April 13–2016.

33 

Coghlan A: Gene Therapy Approved. New Scientist. 230:8–9. 2016. View Article : Google Scholar

34 

Cyranoski D: Chinese scientists to pioneer first human CRISPR trial. Nature. 535:476–477. 2016. View Article : Google Scholar : PubMed/NCBI

35 

Yamanishi Y, Boyle DL, Rosengren S, Green DR, Zvaifler NJ and Firestein GS: Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc Natl Acad Sci USA. 99:10025–10030. 2002. View Article : Google Scholar : PubMed/NCBI

36 

Firestein GS, Echeverri F, Yeo M, Zvaifler NJ and Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA. 94:10895–10900. 1997. View Article : Google Scholar : PubMed/NCBI

37 

Rème T, Travaglio A, Gueydon E, Adla L, Jorgensen C and Sany J: Mutations of the p53 tumour suppressor gene in erosive rheumatoid synovial tissue. Clin Exp Immunol. 111:353–358. 1998. View Article : Google Scholar : PubMed/NCBI

38 

Kullmann F, Judex M, Neudecker I, Lechner S, Jüsten HP, Green DR, Wessinghage D, Firestein GS, Gay S, Schölmerich J and Müller-Ladner U: Analysis of the p53 tumor suppressor gene in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 42:1594–1600. 1999. View Article : Google Scholar : PubMed/NCBI

39 

Yao Q, Wang S, Glorioso JC, Evans CH, Robbins PD, Ghivizzani SC and Oligino TJ: Gene transfer of p53 to arthritic joints stimulates synovial apoptosis and inhibits inflammation. Mol Ther. 3:901–910. 2001. View Article : Google Scholar : PubMed/NCBI

40 

Cha HS, Rosengren S, Boyle DL and Firestein GS: PUMA regulation and proapoptotic effects in fibroblast-like synoviocytes. Arthritis Rheum. 54:587–592. 2006. View Article : Google Scholar : PubMed/NCBI

41 

Thin TH, Li L, Chung TK, Sun H and Taneja R: Stra13 is induced by genotoxic stress and regulates ionizing-radiation-induced apoptosis. EMBO Rep. 8:401–407. 2007. View Article : Google Scholar : PubMed/NCBI

42 

Dudgeon C, Peng R, Wang P, Sebastiani A, Yu J and Zhang L: Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth. Oncogene. 31:4848–4858. 2012. View Article : Google Scholar : PubMed/NCBI

43 

Yu J, Yue W, Wu B and Zhang L: PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation. Clin Cancer Res. 12:2928–2936. 2006. View Article : Google Scholar : PubMed/NCBI

44 

Gupta S, Afaqa F and Mukhtar H: Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene. 21:3727–3738. 2002. View Article : Google Scholar : PubMed/NCBI

45 

Xiao D, Vogel V and Singh SV: Benzyl isothiocyanate-induced apoptosis in human breast cancer cells is initiated by reactive oxygen species and regulated by Bax and Bak. Mol Cancer Ther. 5:2931–2945. 2006. View Article : Google Scholar : PubMed/NCBI

46 

Xiao D, Lew KL, Kim YA, Zeng Y, Hahm ER, Dhir R and Singh SV: Diallyl trisulfide suppresses growth of PC-3 human prostate cancer xenograft in vivo in association with Bax and Bak induction. Clin Cancer Res. 12:6836–6843. 2006. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Shan Z, Liu Q, Li Y, Wu J, Sun D and Gao Z: PUMA decreases the growth of prostate cancer PC-3 cells independent of p53. Oncol Lett 13: 1885-1890, 2017.
APA
Shan, Z., Liu, Q., Li, Y., Wu, J., Sun, D., & Gao, Z. (2017). PUMA decreases the growth of prostate cancer PC-3 cells independent of p53. Oncology Letters, 13, 1885-1890. https://doi.org/10.3892/ol.2017.5657
MLA
Shan, Z., Liu, Q., Li, Y., Wu, J., Sun, D., Gao, Z."PUMA decreases the growth of prostate cancer PC-3 cells independent of p53". Oncology Letters 13.3 (2017): 1885-1890.
Chicago
Shan, Z., Liu, Q., Li, Y., Wu, J., Sun, D., Gao, Z."PUMA decreases the growth of prostate cancer PC-3 cells independent of p53". Oncology Letters 13, no. 3 (2017): 1885-1890. https://doi.org/10.3892/ol.2017.5657
Copy and paste a formatted citation
x
Spandidos Publications style
Shan Z, Liu Q, Li Y, Wu J, Sun D and Gao Z: PUMA decreases the growth of prostate cancer PC-3 cells independent of p53. Oncol Lett 13: 1885-1890, 2017.
APA
Shan, Z., Liu, Q., Li, Y., Wu, J., Sun, D., & Gao, Z. (2017). PUMA decreases the growth of prostate cancer PC-3 cells independent of p53. Oncology Letters, 13, 1885-1890. https://doi.org/10.3892/ol.2017.5657
MLA
Shan, Z., Liu, Q., Li, Y., Wu, J., Sun, D., Gao, Z."PUMA decreases the growth of prostate cancer PC-3 cells independent of p53". Oncology Letters 13.3 (2017): 1885-1890.
Chicago
Shan, Z., Liu, Q., Li, Y., Wu, J., Sun, D., Gao, Z."PUMA decreases the growth of prostate cancer PC-3 cells independent of p53". Oncology Letters 13, no. 3 (2017): 1885-1890. https://doi.org/10.3892/ol.2017.5657
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team